Stramsen is offering huge discounts of up to 80% for its Reg A and Reg D offerings HOUSTON, March 11, 2025 /PRNewswire/ — In a strategic move to enhance investor relations and capital management capabilities, Stramsen Biotech Inc. has forged a powerful alliance with Nasdaq Private Market…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.